SCOPUS 정보 검색 플랫폼

Experimental Hematology

Volumn 29, Issue 3, 2001, Pages 286-294

Latent hematopoietic stem cell toxicity associated with protracted drug administration

(5) Keyes, Kristan A a,c Segovia, José Carlos b Bueren, Juan A b Parchment, Ralph E a Albella, Beatriz b

a WAYNE STATE UNIVERSITY (United States)

b CIEMAT (Spain)

c ELI LILLY AND COMPANY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLDINALINE; ANTINEOPLASTIC AGENT; GEMCITABINE; MELPHALAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; CELL DAMAGE; COLONY FORMING UNIT; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; COLONY-FORMING UNITS ASSAY; CROSSES, GENETIC; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INJECTIONS, INTRAPERITONEAL; MALE; MELPHALAN; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; PHENYLENEDIAMINES; TIME FACTORS;

EID: 0035099283 PISSN: 0301472X EISSN: None Source Type: Journal
DOI: 10.1016/S0301-472X(00)00670-6 Document Type: Article

Times cited : (8)

References (19)

1
- 0028357995
- Phase I trial of low-dose continuous topotecan infusion in patients with cancer; an active and well-tolerated regimen
- (1994) J Clin Oncol , vol.12 , pp. 553
- Hochster, H.¹ Liebes, L.² Speyer, J.³

2
- 0024539308
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma; a Mid-Atlantic Oncology Program study
- (1989) J Clin Oncol , vol.7 , pp. 425
- Lokich, J.J.¹ Ahlgren, J.D.² Gullo, J.J.³ Phillips, J.A.⁴ Fryer, J.G.⁵

3
- 85046166507
- Preclinical antitumor activity of CI-994
- (1996) Invest New Drugs , vol.15 , pp. 187
- LoRusso, P.M.¹ Demchik, L.² Foster, B.³

4
- 0005895022
- th NCI-EORTC Symposium on New Drugs. I. Cancer Therapy, Amsterdam, March 12-15

5
- 0005785092
- Phase I trial of CI994 (abstract)
- (1997) Proc ASCO , vol.16 , pp. 74
- LoRusso, P.M.¹ Wozniak, A.² Foster, B.³

6
- 0028105119
- Schedule dependence of sensitivity to 2′2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumor cell lines and solid tumors
- (1994) Biochem Pharmacol , vol.48 , pp. 1327
- Ruiz van Haperen, V.W.¹ Veerman, G.² Boven, E.³ Noordhuis, P.⁴ Vermorken, J.B.⁵ Peters, G.J.⁶

7
- 0028889426
- Schedule-dependent antitumor effect of gemcitabine in in vivo model system
- [/3a]
- (1995) Semin Oncol , vol.22 , Issue.4 Suppl 11 , pp. 42
- Braakhuis, B.J.¹ Ruiz van Haperen, V.W.² Boven, E.³ Veerman, G.⁴ Peters, G.J.⁵

8
- 0029666336
- Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors
- (1996) Cancer Chemother Pharmacol , vol.38 , pp. 335
- Veerman, G.¹ Ruiz van Haperan, V.W.² Vermorken, J.B.³

9
- 0034083408
- Cytotoxic chemotherapy regimens that increase dose per cycle (dose intensity) by extending daily dosing from five consecutive days to 28 consecutive days and beyond
- (2000) Clin Cancer Res , vol.6 , pp. 2474
- Keyes, K.A.¹ Albella, B.² LoRusso, P.M.³ Bueren, J.A.⁴ Parchment, R.E.⁵

10
- 0021843548
- Stem cell defects after cytoreductive therapy in man
- [/3a]
- (1985) Exp Hematol , vol.13 , Issue.Suppl 16 , pp. 31
- Schreml, W.¹ Lohrmann, H.P.² Anger, B.³

11
- 0027893247
- Primitive hematopoietic stem cells; direct assay of the most productive populations by competitive repopulation with simple binomial, correlation, and covariance calculations
- (1993) Exp Hematol , vol.21 , pp. 206
- Harrison, D.¹ Jordan, C.² Zhong, R.K.³ Astle, C.⁴

12
- 0027163483
- Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay
- (1993) Cancer Chemother Pharmacol , vol.32 , pp. 450
- Gardner, R.V.¹ Lerner, C.² Astle, C.M.³ Harrison, D.E.⁴

13
- 0030786421
- Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy
- (1997) Exp Hematol , vol.25 , pp. 495
- Gardner, R.V.¹ Astle, C.M.² Harrison, D.E.³

14
- 0005784203
- Van Os R, Robinson S, Sheriden T, Mislow JMK, Dawes D, Mauch PM (1998) Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents. Blood 92:1950

15
- 0013914584
- The growth of mouse bone marrow cells in vitro
- (1966) Aust J Exp Biol Med Sci , vol.44 , pp. 287
- Bradley, T.R.¹ Metcalf, D.²

16
- 0029950294
- Relevance of myeloablative conditioning in the engraftment of limiting numbers of normal and genetically marked lympho-hematopoietic stem cells
- (1996) Bone Marrow Transplant , vol.18 , pp. 981
- Varas, F.¹ Bernard, A.² Almendral, J.M.³ Bueren, J.A.⁴

17
- 0031936092
- Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors
- (1998) Exp Hematol , vol.26 , pp. 100
- Varas, F.¹ Bernad, A.² Bueren, J.A.³

18
- 0018096510
- Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice
- (1978) Cancer Treatment Reports , vol.62 , pp. 533
- Harrison, S.D.¹ Denine, E.P.² Peckham, J.C.³

19
- 0033557642
- Increasing dose intensity of cisplatin-etoposide in advanced non-small cell lung carcinoma; a Phase III randomized trial of the Spanish Lung Cancer Group
- (1999) Cancer , vol.15 , pp. 855
- Font, A.¹ Moyano, A.J.² Puerto, J.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.